Catechins inhibit atherosclerosis in male rats on a high fat diet

Main Article Content

Erna Susanti
Achmad Rudijanto
Retty Ratnawati

Abstract

Background
A catechin isolate from the green tea clone GMB 4, which shows antioxidant activity, may be a candidate drug for prevention of atherosclerosis. The aim of this study was to analyze the effect of catechin on endothelial nitric oxide synthase (eNOS) and p110 phosphoinositide 3-kinase inhibitor (PI3K) expression and on p38 mitogen activated protein kinase (MAPK) activity in male rats fed a high fat diet.

Methods
Twenty five male Wistar rats were divided into the following five groups: rats on standard diet; rats on high fat diet; rats on high fat diet + catechin 3 mg/day; rats on high fat diet + catechin 6 mg/day; and rats on high fat diet + catechin 24 mg/day. eNOS and p110 PI3K expression and p38 MAPK activity were measured by means of ELISA.

Results
High fat diet significantly increased eNOS expression, decreased p110 PI3K expression, and increased p38 MAPK activity in male rats, in comparison with standard diet (p<0.05). Administration of 3 mg/day catechin decreased eNOS expression compared to that in the high fat diet group without catechin (p<0.05). The administration of catechin increased p100 PI3K expression to a similar extent as that in the high fat diet groups with catechin 6 mg/day and 24 mg/day. Administration of catechin at all doses decreased p38 MAPK activity to the level of the standard diet group.

Conclusions
High fat diet increases eNOS expression, decreases PI3K expression, and increases p38 MAPK activity. Administration of catechin decreases eNOS expression, increases PI3K expression, and decreases p38 MAPK activity.

Article Details

How to Cite
Susanti, E., Rudijanto, A., & Ratnawati, R. (2012). Catechins inhibit atherosclerosis in male rats on a high fat diet. Universa Medicina, 31(2), 81–87. https://doi.org/10.18051/UnivMed.2012.v31.81-87
Section
Review Article

References

World Health Organization. Deaths from coronary heart disease. Geneva: World Health Organization; 2003.

Yang Z, Ming XF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res Rev 2006;4:53-65.

DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing link. Diabetol Rev 2010;53:1270–87.

Muniyappa R, Montagnani M, Kon KK, Guon MJ. Cardiovascular actions of insulin. Endocrine Rev 2007;28:463-91.

Ratnawati R, Ciptati, Satuman. Isolasi EGCG dari teh hijau klon GMB4 Jawa Barat. Laporan penelitian Program Insentif Riset Dasar, RISTEK Kementerian Negara Riset dan Teknologi. 2009.

Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, Keaney JF. Activation of endothelial nitric oxide synthase by the p38 mapk in response to black tea polyphenols. Am Soc Biochem Mol Biol 2004;279:4637-43.

Lorens M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, et al. A constituent of green tea, EGCG, activates eNOS by a phosphatidylinositol-3- OH- kinase, cAMP-dependent protein kinase, and Akt-dependent pathway and leads to endothelial dependent vasorelaxation. J Biol Chem 2003;279:6190-5.

Stangl V, Dreger H, Stangl K, Lorenz M. Moleculer targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007;73: 348-58.

Velayutam P, Babu A, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem 2008;15:1840-50.

Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde modified LDL in men. Am J Clin Nutr 2005;81:122-9.

Ali M, Muliartha IK. Optimization of high-fat diet in rats models on atherogenik diet. UB Medical Journal 2004;3:15-21.

Aulanni’am. Principles and techniques of Biomolecular analysis 2003.p.78-81.

Salimi S, Firoozrai M, Mourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron4 VNTR polymorphisms in patients with coronary artery disease in Iran. Indian J Med Res 2006;124:683-8.

Li P, Kim SW, Li X, Datta S, Pond WG, Wu G. Dietary supplementation with cholesterol and docosahexanoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. Nitric Oxide 2008;19:259-65.

Jagnandan D, Sessa WC, Fulton D. Intracellular location regulate calcium-calmodulin-dependent activation of organelle-restricted eNOS. Am J Physiol Cell Physiol 2005;289:C1024-C33.

Ohkita M, Sugii M, Kitamura A, Mori T, Hayashi T, Takaoka M, et al. Differential effects of different status on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells. Exp Biol Med 2006;231: 772-6.

Benito S, Lopez D, Saiz MP, Buxaderas S, Sanchez J, Puig-Parellada P, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 2002;135:910-6.

Yamakuchi M, Bao C, Ferlito M, Lowenstein CJ. Epigallocathechin gallate inhibits endothelial exocytosis. Biol Chem 2008;389: 935-41.

Steffen YM, Schewe T, Sies H. (-) epicathecin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Bioch Biophys Res Comm 2007;359:828-33.

Ou H, Song T, Yeh Y, Huang C, Yang S, Chiu T, et al. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Applied Physiol 2010;108:1745-56.

Joo S, Song Y, Park Y, Myung E, Chung C, Park K, et al. Epigallocathecin-3-gallate inhibits LPS-induced NF-kB and MAPK signalling pathways in bone marrow-derived macrophages. Gut Liver 2012;6:188-96.

Hemi R, Yochananov Y, Barhod E, Kasher-Meron M, Karasik A, Tirosh A, et al. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family. A novel common mechanism for stress-induced IRS-1 serine phophorylation and insulin resistance. Diabetes 2011;60:1134-45.

Choi Y, Jeong Y, Lee Y, Kwon H, Kang Y. (-) epigallocathecin gallate and quercetin enhance survival signalling in response to oxidant-induced human endothelial apoptosis. J Nutr 2005;135:707-13.

Kim HS, Kim MH, Jeong M, Hwang YS, Lim SH, Shin BA, et al. ECGC blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res 2004; 24:747-54.